In addition to the regulation of clot formation, the protease thrombin can also have a direct effect on cancer cells and the cells of the tumor microenvironment (TME) through its ability to interact with the protease-activated receptor-1 (PAR-1), a G-protein coupled receptor encoded by the gene F2R. The gene discussed is F2R; the disease is cancer.